GC Biopharma Corp. (006280.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 1.81T |
| Enterprise Value | 2.75T |
| P/E Ratio | -27.91 |
| PEG Ratio | 0.25 |
| Price/Sales Ratio | 0.71 |
| Price/Book Ratio | 0.63 |
| Enterprise/Revenue | 1.17 |
| Enterprise/EBITDA | 16.21 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.03 |
| Operating Margin | 0.02 |
| Return On Assets | -0.02 |
| Return On Equity | -0.04 |
| Revenue | 1.99T |
| Revenue/Share | 305,529.07 |
| Gross Profit | 536B |
| EBITDA | 155.46B |
| Net Income | -4.67B |
| Diluted EPS | -409.51 |
| Total Cash | 44.66B |
| Total Cash/Share | 6,947.42 |
| Total Debt | 938.85B |
| Total Debt/Equity | 0.76 |
| Current Ratio | 1.35 |
| Book Value Per Share | 206,315.4 |
| 52-Week Change | -6.51 |
| 52-Week High | 183,800 |
| 52-Week Low | 105,900 |
| Moving Average 50 Days | 123,294 |
| Moving Average 200 Days | 142,543.5 |
| Average Volume | 48,990 |
| Shares Outstanding | 11.41M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1,500 |
| Trailing Annual Dividend Yield | 1.23 |
| Payout Ratio | -0.39 |
| Last Split Factor | 21:20 |
| Last Split Date | June 07, 2013 |